Intracranial Abscess Treatment Market Analysis

  • Report ID: 3444
  • Published Date: Jun 25, 2025
  • Report Format: PDF, PPT

Intracranial Abscess Treatment Market Segmentation:

Treatment Segment Analysis

The surgery segment in the intracranial abscess treatment market is anticipated to garner a maximum share of 75.4% due to its efficacy in treating severe cases, especially epidural abscesses. Such complicated cases need decompression techniques to prevent any severity, such as brain damage. Bacterial infections require surgical procedures for life-threatening situations. The World Health Organization reports that almost 21-50 million cases of abscess occur due to road accidents, requiring surgery. Other than this, the Centers for Disease Control and Prevention reported that 30.1% of brain abscess cases currently include resistant pathogens, requiring resection.

Type Segment Analysis

The intracranial segment in the intracranial abscess treatment market is projected to garner a 72.3% share due to higher prevalence amongst the population. The National Institutes of Health showcase that intracranial abscesses usually occur from infections prevalent all over the world. Other than this, the World Health Organization reported in 2023 that in India, post-pandemic fungal infections caused a surge in intracranial abscess cases by 27.2%. Moreover, the Radiology Society in 2023 asserted that the inclusion of MRI technologies escalated by 9.2% in the last 5 years, primarily because it gives enhanced diagnosis of cases with abscess encapsulation. The state-of-the-art methods for diagnostic imaging render early detection, further propelling the demand for targeted treatments.

Our in-depth analysis of the global intracranial abscess treatment market includes the following segments:

Segment

Subsegment

Type

  • Intracranial
  • Intraspinal

Treatment

  • Antibiotics
  • Antifungal Drugs
  • Surgery

Origin

  • Head Injury
  • Ear Infection
  • Chronic Sinusitis
  • Neurosurgery

End user

  • Hospitals
  • Specialty Clinics
  • Pharmacies

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of intracranial abscess treatment is assessed at USD 1.15 billion.

Intracranial abscess treatment market size was valued at USD 1.08 billion in 2024 and is projected to reach approximately USD 2.1 billion by the end of 2037, rising at a CAGR of 6.4% during the forecast period, 2025–2037

The North America intracranial abscess treatment market is projected to register a 38.2% market share by 2037, garnering a CAGR of 6.7% during the forecasted period

The major players in the market are Teva Pharmaceutical Industries Ltd., Johnson & Johnson (Janssen), Baxter International Inc., B. Braun Melsungen AG, Novartis AG, Sanofi S.A., Gilead Sciences, Amneal Pharmaceuticals LLC, Par Pharmaceutical, Mylan N.V., Teikoku Seiyaku Co., Aspen Pharmacare, Celltrion Healthcare, Cipla Ltd., Sun Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos